Download retail market belorussia

Belarusian Pharmaceutical Industry: Review
Overview
Core characteristics of the industry
• Market capacity - 618 mln $;
• The market is represented by 26 companies,
5 of which are state-owned; share of the
Belarusian producers output in value terms
amounts to 30,6%;
• Health budget expenses – 5,8% GDP;
• Products are exported to 25 countries (96% of
which refer to CIS);
• Imported from 59 countries (CIS, EU, Asia);
• OTC drugs sales share – 42% (which also
means 3th position among CIS).
Key indicators
2012
Output, mln $
302
Export, mln $
113
Import, mln $
429
Per capita consumption, $
65
Number of pharmacies
2802
Number of hospitals
Local and foreign producers market
shares, %
644
Market capacity, mln $
676.5
650.0
foreign
79%
producers
76.6%
76.5%
69.4%
96%
618.0
615.4
95%
110%
local
producers
21%
23.4%
23.5%
30.6%
2009
2010
2011
2012
2009
2010
2011
2012
* Volume decrease took place due to the saturation of the
domestic market by cheap drugs of home manufacture
Drugs sales structure, %
57,1
Consumers
spending
42,9
Government spending
Including free and reduced-price
issue – 17,9%
Retail and hospital market segments
shares, %
Pharmaceutical industry’s survey
The most popular groups of drugs, 2012
(according to wholesale volumes, mln $)
53.7
Price structure of retail and hospital
market segments , %
More than 50 $
20 – 50 $
43.9
32.4 30.8
26.3
24.4
5.3
7.2
10 – 20 $
15.3
5 – 10 $
22.4
45.3
8.4
21.7 21.2 20.9
15.6
18.3
1-5$
37.9
10.6
10.5
Less than 1 $
C
D
E
F
G
H
I
Systemic antibacterial agents
B
Antineoplastic drugs
C
Agents affecting on the renin-angiotensin system
D
E
F
G
H
Anticatarrhal and antitussive drugs
Antiphlogistic and antirheumatic agents
Drugs for diabetes treatment
Vitamins
Vaccines
I
Cardiac therapy
J
Drugs for eye diseases treatment
Hospital market,%
Human resource
Number of specialists
8303
Graduates, annually
500
R&D specialists
372
Specialists with academic degree
58
Average wages, $ monthly
477
23.4
23.4
23.3
22.7
Bayer HealthCare
25.8
Pharmland
28.4
Sanofi-aventis
29.3
Novartis
32.0
Roshe
Borimed
35.7
Gedeon Richter
ТОP-10 manufacturing companies, 2012 (according to
wholesale volumes, mln $)
56.5
Belmedpreparaty
Retail market, %
J
А
9.7
Lekpharm
B
Nycomed
(cons. of Takeda)
A
12.0